Cyanocobalamin Injection, USP is a sterile solution of cyanocobalamin for intramuscular or subcutaneous injection
In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells
This product is intended solely for research purposes and is not for human consumption
SeekPeptides has built one of the most comprehensive peptide education libraries available, covering everything from immune system support to inflammation management to muscle growth optimization
The lyophilized form is stable at room temperature for brief periods during shipping and handling